Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 20, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for January 12, 2006 Subscribe to this News Feed      
 

Special Glasses Block Cancer Stimulating Light

Glasses that block blue light allow cancer fighting melatonin to flow.

For Immediate Release

University Heights, OH (PRWEB) January 12, 2006 -- A press release from the National Institute for Environmental Health Sciences states “Results from a new study in laboratory mice show that nighttime exposure to artificial light stimulated the growth of human breast tumors by suppressing the levels of a key hormone called melatonin. The study also showed that extended periods of nighttime darkness greatly slowed the growth of these tumors.” 12/19/2005

Results from a new study in laboratory mice show that nighttime exposure to artificial light stimulated the growth of human breast tumors by suppressing the levels of a key hormone called melatonin. The study also showed that extended periods of nighttime darkness greatly slowed the growth of these tumors.
Light is known to suppress the secretion of melatonin, a powerful antioxidant and cancer fighter. It is also known it is the blue rays in ordinary light that suppress melatonin. Physicists at John Carroll University have identified eye glasses that remove the blue rays. They recommend that people at high risk for cancer put on the glasses in the evening to get melatonin flowing.

Scientists at Toronto University have proven that wearing goggles with filters that block the blue light allow people to make melatonin even though exposed to bright lights. Putting on blue-blocking glasses in the evening is thus a means for getting melatonin to be present for a longer time to fight cancer. Blocking blue light is the same as darkness (“virtual darkness”) for the pineal gland that makes melatonin.

Studies show that blind people and people who consistently sleep unusually long (9 hours or more) have a significantly lower cancer rate. They also produce melatonin for a longer time. This is consistent with the idea that avoiding light that suppresses melatonin during the evening will reduce the risk of cancer. It may take the body a number of days to adjust to wearing the glasses so patience is necessary. The glasses should not be worn all the time, as having melatonin present in the morning is thought to be the cause of S.A.D. which is successfully treated by exposure to blue light.                

Studies with turkey hens with ovarian cancer showed that doubling the time they were held in darkness each day from 8 hours to 16 hours resulted in decreased tumor growth and complete remission in some birds. There is a huge difference between turkeys and humans so caution is necessary in drawing any conclusions. It is suggestive however, that long periods of real darkness combined with “virtual darkness” might be useful for patients with cancer. Melatonin has been shown to be beneficial in combination with some forms of chemotherapy and radiation therapy.

Special glasses and light bulbs that block blue light, and filters for TV and computers screens are all available at www.lowbluelights.com.

Contact:
Dr. Richard Hansler
28120 Belcourt Rd.
Pepper Pike, OH 44124
(216) 397-1657

###

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Richard Hansler
LIGHTING INNOVATIONS
216 397 1657
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright